ArticleCardiology journal2021

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.

Jacek Kubica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.